All Immunology articles
-
NewsResearch alert: Bacterial chatter slows wound healing
Researchers have discovered a previously unrecognized mechanism by which Staphylococcus aureus delays wound healing. The study finds that quorum sensing is a key driver of delayed healing in wounds infected by S. aureus.
-
NewsCombination of pre- and probiotics offers superior anti-inflammatory benefits compared with omega-3 or prebiotic alone
A new study has found that combining certain types of dietary supplements is more effective than single prebiotics or omega-3 in supporting immune and metabolic health, which could lower the risk of conditions linked to chronic inflammation.
-
NewsHuman Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy.
-
NewsSynthetic biology reprograms plant–microbe partnerships for resilient agriculture
By integrating engineering principles with plant biology, a new review highlights how redesigned genetic pathways and plant-based biosensors can deepen understanding of plant responses to both harmful and beneficial microbes.
-
NewsResearchers discover method to combat antibiotic treatment failure
Researchers explored ways to alter our own immune cells to help antibiotics work more effectively. They identified a small molecule that alters the body’s immune cells, forcing them to ’wake up’ dormant bacteria and make them more vulnerable to antibiotic treatment.
-
NewsCould cardamom seeds be a potential source of antiviral treatment?
Researchers have found that cardamom seed extract, as well as its main bioactive ingredient, 1,8-cineole, can have potent antiviral effects through its ability to enhance the production of antiviral molecules known as type I interferons via nucleic acid ‘sensors’ inside cells.
-
NewsSafer, more effective vaccines with new mRNA vaccine technology
A new messenger ribonucleic acid (mRNA) vaccine technology could make future vaccines safer, more effective, and less burdensome for patients. The new approach uses albumin-recruiting lipid nanoparticles to deliver mRNA precisely to lymph nodes while bypassing the liver.
-
NewsNew study reveals diverse threats from Avian E. coli
New research has determined why various strains of Avian Pathogenic E. coli behave so differently. The study analysed a colibacillosis outbreak in turkeys in the UK, and found a strain called ST-101 was the dominant cause of the outbreak, accounting for nearly 60% of cases.
-
NewsCould targeted steroid use offer a universal complimentary treatment to fight TB?
Newly published research provides evidence that treating patients with steroids may enhance the function of their macrophages to kill the mycobacteria, while diminishing pathways of inflammatory damage.
-
NewsMeasles immunity 90% in BC’s Lower Mainland
In British Columbia’s Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study.
-
NewsTwo-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The results suggest individuals vaccinated with ZVL should be revaccinated with two doses of RZV.
-
NewsPioneering gut health testing with a simple finger prick
Zinzino, the Scandinavian health and wellness company, has announced the launch of its innovative Gut Health Test. With a simple at-home finger prick, this is the first commercial test to measure what gut bacteria produce and how the body responds.
-
NewsEngineered bacterial therapy activates immune response in cancer preclinical studies
Researchers have developed a new bacterial immunotherapy that delivers immune-activating proteins directly to solid tumors, which can often suppress the immune system. ACTM-838 targets phagocytic immune cells within the tumor microenvironment.
-
NewsIn a nasal spray, gold nanoparticles deliver a targeted treatment to the brain
In the form of a ‘nasal spray’, tiny gold particles act as carriers, delivering a treatment directly to the brain: a new nanotechnological device for the treatment and prevention of neuropsychiatric and neurodegenerative diseases and infections.
-
NewsResearch team with the latest Nobel Prize laureate reveals regulatory immune cell precursors disrupted in severe COVID-19
A research team joined by Professor Shimon Sakaguchi – the latest Nobel Laureate in Physiology or Medicine – has identified a subset of immune cells called precursor T follicular regulatory cells (preTfr) that play a critical role in preventing autoantibody production.
-
NewsChanges in gut microbiota influence which patients get AIG-related neuroendocrine tumors
Researchers have discovered how the balance of bacteria in the stomach affects the growth of neuroendocrine tumors (NETs). By identifying the specific bacteria involved and the biochemical reactions that cause tumor growth, they hope to detect which patients are most likely to develop cancer.
-
NewsResearchers find key to stopping deadly infection
New research has identified a key step that enables rotavirus to infect cells. The researchers found that disabling the process in tissue culture and in mice prevented infection.
-
NewsMitochondria & microbiota: Targeting Extracellular Vesicles 2025 to explore game-changing pathways in medicine
The Second World Congress on Targeting Extracellular Vesicles (EVs) is scheduled for 15–16 October 2025 in Valencia, Spain. This event will spotlight the rapidly evolving science where mitochondrial biology and microbiome research intersect via extracellular vesicles.
-
NewsTrailblazing Young Scientists honored with $250,000 prizes at Blavatnik National Awards Gala
Three of America’s most promising young scientists were awarded top honors at the 2025 Blavatnik National Awards for Young Scientists, one of the country’s most significant prizes for early-career researchers. The Life Sciences Laureate was Philip J. Kranzusch, Harvard Medical School (Microbiology).
-
NewsNew study reveals where HIV hides in different parts of the body
A new study reveals that HIV cloaks itself in the DNA of infected cells using unique DNA patterns in the brain, blood and parts of the digestive tract. For example, in the brain, the virus avoids genes and hides in less active parts of the DNA.